Systems Developmental Biology for Understanding Embryonic Development and the Ontogeny of Structural Birth Defects (R01)

The summary for the Systems Developmental Biology for Understanding Embryonic Development and the Ontogeny of Structural Birth Defects (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Systems Developmental Biology for Understanding Embryonic Development and the Ontogeny of Structural Birth Defects (R01): The purpose of this funding opportunity announcement (FOA) is to promote systems developmental biology. In the context of this FOA, systems developmental biology is defined as research focused on understanding how biological components work together to produce the complex biological phenomena encompassing embryonic development.

Federal Grant Title:	Systems Developmental Biology for Understanding Embryonic Development and the Ontogeny of Structural Birth Defects (R01)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health Income Security and Social Services
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-17-454
Type of Funding:	Grant
CFDA Numbers:	93.865
CFDA Descriptions:	Information not provided
Current Application Deadline:	December 6th, 2019
Original Application Deadline:	December 6th, 2019
Posted Date:	August 8th, 2017
Creation Date:	August 8th, 2017
Archive Date:	January 11th, 2020
Total Program Funding:
Maximum Federal Grant Award:	$499,999
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	August 8th, 2017

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PAR-17-454.html
Grant Announcement Contact: NIH OER Webmaster
[email protected]

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Early Immune System Development and Ontogeny (R01 Clinical Trial Optional); • Rehabilitation Research Career Development Programs (K12 Clinical Trial Optional); • Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - ...; • Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - ...; • Contraceptive Development Research Centers (P50 Clinical Trial Optional); • Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Precli...; • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...; • Reproductive Genetics and Epigenetics
More Grants from the National Institutes of Health: • New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not All...; • Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional); • Intervention Research to Improve Native American Health (R01 Clinical Trial Optional); • Intervention Research to Improve Native American Health (R34 Clinical Trial Optional); • NIA Predoctoral Fellowship Award to Promote Broad Participation in Translational Research ...